Intech’s COVID-19 Response Update Read Now

Please Choose Your Country

Welcome. This website is intended solely for the use of institutional investors, consultants and other professionally recognized financial intermediaries in specific countries. Intech Investment Management LLC (“Intech”), is an investment adviser registered with the United States Securities & Exchange Commission. Intech is not permitted to offer products and services in all countries. It is the responsibility of prospective investors to inform themselves of and to observe all applicable laws and regulations of any relevant jurisdictions, including the legal requirements and tax consequences within the countries of their citizenship, residence, domicile and place of business with respect to the acquisition, holding or disposal of shares or securities, and any foreign exchange restrictions that may be relevant thereto. The products and services referred to in this website are not offered to any person or entity in any jurisdiction where the advertisement, offer or sale of such products and services is restricted or prohibited by law or regulation or where we would be subject to any registration or licensing requirement not currently held by Intech or our affiliates. If Intech does not offer a website for your country, please visit

For U.S. and Canadian Institutional Investors Only

Information contained in this area of the Website is published solely for general informative purposes and intended only for United States and Canadian institutional investors, consultants, financial advisers, and other intermediaries who are who are knowledgeable and experienced in the financial services market and in investment products of this nature. If you are a retail, individual investor or non-ultra-high net worth individual then please leave this website immediately. The information is not authorized for use in a jurisdiction where distribution is not authorized and is not intended for distribution to retail clients, the general public or retail investors. If you choose to access this Website from locations outside of the United States or Canada, you do so at your own initiative and risk, and are responsible for compliance with all applicable laws.

U.S. Institutional Investors: By accessing this site you confirm that you are an U.S. Institutional Investor, you agree not to forward or make the contents of this site available to any person who is not an U.S. Institutional Investor, and you agree to be subject to terms of use.

Canadian Institutional Investors: By accessing this site you confirm that you are a “permitted client” as defined in National Instrument 31-103 Registration Requirements, Exemptions and Ongoing Registrant Obligations of the Canadian Securities Administrators, you agree not to forward or make the contents of this site available to any person who is not a “permitted client”, and you agree to be subject to terms of use. The information on this Website is for informational purposes only and does not constitute (i) an offer for products or services or (ii) the provision of investment advice of any kind, tailored or otherwise. The information on this Website should also not be construed as an offer to sell or a solicitation of an offer to buy to any persons who are prohibited from receiving such information under the laws applicable to their place of citizenship, domicile or residence. Intech Investment Management LLC (“Intech”) does not have any funds that offer securities under a simplified prospectus for general offer or sale within Canada. No securities regulatory authority in Canada has reviewed or in any way passed upon this website or the merits of any investment available, and any representation to the contrary is an offense. Intech is registered with the United States Securities & Exchange Commission under the Investment Advisers Act of 1940. Intech is a subsidiary of Janus Henderson Group plc, and is affiliated with its subsidiaries and affiliates.

Redirect Me to

Intech Insights®

Intech Celebrates Pi Day!

March 13, 2020

Celebrating Pi (π) Day (March 14th or, sometimes, July 22nd)1 is a great chance to spread the word that math is exciting and fun. In many ways, math is like a game: there are rules, but the...

Has This Coronavirus Taken Us by Surprise?

March 10, 2020

Nassim Taleb popularized the black swan in his eponymous book. He described it as an event that’s highly surprising, highly disruptive, and, in hindsight, deemed obvious by market participants. The...

Is There Really a “Free Lunch” in Investing?

February 28, 2020

A couple of weeks ago, I received an email from an old friend with the subject: Sound Familiar? It contained a link to an article in Financial Advisor Magazine where the author describes “the free...

How to Overcome Challenges in ESG Data

February 12, 2020

Separating ‘naughty’ from ‘nice’ in a verified list is no longer a seasonal activity limited to residents of the Arctic Circle. Investors and managers have been steadily increasing their utilization...

What Posts and Papers are Your Favorite?

January 30, 2020

As you might imagine, we like data – even website data. And that data tells us what topics you found most interesting in 2019. Below is a list of the top five most popular blog posts and white papers...

It’s Time to Challenge Your View on Risk

January 20, 2020

New year, new you, right? Every year I seem to go back to the drawing board and evaluate how I can improve myself. This involves self-reflection and insight into where I am and where I want to be. It...

The Signs of Tail Risk We're Seeing Now

January 8, 2020

Forecasts for 2020 are easy to come by, but market efficiency makes these prognostications difficult to exploit in a directional sense. Instead, by examining the relative behavior of stocks, we...

Is There a Better Way to Think About Factor Investing?

December 17, 2019

The popularity of factor investing appears to be at a crossroad. While investors’ adoption of factors has never been broader, their concerns about the effectiveness of factor investing are...

Do You Need to Change Your Factor Prescriptions?

December 12, 2019

Only the United States and New Zealand allow direct-to-consumer advertising for prescription drugs. In the U.S. alone, pharmaceutical companies spend nearly $10 billion annually to advertise drugs.1...

For the Love of Money – The O’Jays

December 9, 2019

Our industry lives in a world of ratios. We love derivatives, but in the end, it’s all about tangible results: money. In a defined contribution context, financial outcomes are what really matter to...